BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 23210402)

  • 21. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
    Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a formulation containing Serenoa repens, Crocus sativus and Pinus massoniana extracts in men with concomitant LUTS and erectile dysfunction.
    Quarto G; Cola A; Perdonà S
    Minerva Urol Nefrol; 2017 Jun; 69(3):300-306. PubMed ID: 27583656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Iscussion on the use of hexane extract of Serenoa repens for combination therapy in patients with LUTS/BPH].
    Sivkov AV; Kirpatovskyi VI
    Urologiia; 2021 Mar; (1):131-139. PubMed ID: 33818949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Our experience of using hexane extract of Serenoa Repens fruit (Permixone) in the treatment of LUTS in clinical practice].
    Kuzmenko AV; Gyaurgiev TA; Kuzmenko GA
    Urologiia; 2022 May; (2):84-89. PubMed ID: 35485819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
    Plosker GL; Brogden RN
    Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
    Hizli F; Uygur MC
    Int Urol Nephrol; 2007; 39(3):879-86. PubMed ID: 17203353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
    Argirović A; Argirović D
    Vojnosanit Pregl; 2013 Dec; 70(12):1091-6. PubMed ID: 24450252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts].
    Sivkov AV; Golovanov SA; Zhukova LV
    Urologiia; 2019 Jul; (3):14-22. PubMed ID: 31356008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Novara G; Giannarini G; Alcaraz A; Cózar-Olmo JM; Descazeaud A; Montorsi F; Ficarra V
    Eur Urol Focus; 2016 Dec; 2(5):553-561. PubMed ID: 28723522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of
    Cai T; Cui Y; Yu S; Li Q; Zhou Z; Gao Z
    Am J Mens Health; 2020; 14(2):1557988320905407. PubMed ID: 32274957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
    Mantovani F
    Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
    Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
    Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
    Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
    Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study].
    de la Taille A; Chalret du Rieu Q; Dialla O; Bardin L
    Prog Urol; 2023 Feb; 33(2):66-72. PubMed ID: 36207246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.